Insider Trading History of Owen Adams Catherine

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Owen Adams Catherine since 2024. This trader's CIK number is 1816838. At the time of last reporting, Owen Adams Catherine was the Chief Executive Officer of Acadia Pharmaceuticals Inc. (stock ticker symbol ACAD). Also see all insider trading activities at Acadia Pharmaceuticals Inc.

Note that in the past Owen Adams Catherine also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Agios Pharmaceuticals, Inc. (AGIO) by Owen Adams Catherine

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 AGIO 0 $0 0 $0 4,097 $0
2024 AGIO 0 $0 0 $0 1,976 $0

Yearly summary of insider trading at Acadia Pharmaceuticals Inc (ACAD) by Owen Adams Catherine

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2026 ACAD 0 $0 11,641 $249,932 23,509 $0


Insider trading activities at 2 companies by Owen Adams Catherine:

1. Agios Pharmaceuticals, Inc. (AGIO)

2. Acadia Pharmaceuticals Inc (ACAD)

Table 1. Insider trading of Agios Pharmaceuticals, Inc. (AGIO) by Owen Adams Catherine

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-06-20 AGIO Option Ex 2,120 .00 0
2025-06-13 AGIO Option Ex 1,977 .00 0
2024-06-13 AGIO Option Ex 1,976 .00 0

Table 2. Insider trading of Acadia Pharmaceuticals Inc (ACAD) by Owen Adams Catherine

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2026-03-25 ACAD Sale 11,641 21.47 249,932
2026-03-24 ACAD Option Ex 23,509 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Owen Adams Catherine (Chief Executive Officer of Acadia Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.